Stock of the Week – Humacyte (HUMA)
Our Stock of the Week is Humacyte (HUMA). I’ve been discussing this stock extensively for a while, but with an FDA decision due in about a month and good support on the chart, it looks like an opportune time to evaluate the name. HUMA has developed the Acellular...Stock of the Week – Mereo BioPharma Group (MREO)
Our Stock of the Week is Mereo BioPharma Group (MREO). MREO is a UK-based biotechnology company that focuses on drugs for rare and specialty diseases. It has two key drugs in development. The first is Setrusumab, which is used for rare brittle bone disease. It has...Stock of the Week – Xeris (XERS)
Our Stock of the Week is Xeris (XERS). We have been following XERS for several years and it has been a disappointment despite its tremendous potential. We now believe that it is on the cusp of being recognized as more information is released by its in-house drug...Stock of the Week – Depegar.com (DESP)
Our Stock of the Week is Depegar.com (DESP). DESP is an Argentina-based company that provides online travel services to 2.5 million customers in Latin America. Currently, about 62% of its revenues come from hotel bookings and 37% from airlines. Its largest market is...
RevShark’s New EBook
Sponsored by
